{
    "title": "Canada approves Novavax's COVID-19 vaccine for adults",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-10524113/Canada-approves-Novavaxs-COVID-19-vaccine.html",
    "date": "2022-02-17",
    "keywords": [
        "vaccine",
        "health",
        "booster",
        "covid19",
        "shot",
        "option",
        "vaccination",
        "use",
        "country",
        "canada",
        "novavaxs",
        "technology",
        "product",
        "mrna",
        "officer",
        "tam",
        "demand",
        "thursday",
        "incs",
        "safety",
        "effectiveness",
        "statement",
        "protein",
        "novel",
        "method",
        "pfizerbiontech",
        "canadas",
        "theresa",
        "httpstmsnrtrs3tum8ta",
        "john",
        "trizzino",
        "globe",
        "light",
        "omicron",
        "threat",
        "percentage",
        "process",
        "nuvaxovid",
        "dose",
        "government",
        "shipment",
        "novavax",
        "supply",
        "manufacturing",
        "fraction",
        "company",
        "quarter",
        "guidance",
        "period",
        "food",
        "drug",
        "administration",
        "union",
        "world",
        "organization",
        "reporting",
        "roy",
        "ismail",
        "shakil",
        "bengaluru",
        "editing",
        "syamnath",
        "lisa",
        "shumaker"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}